HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation
Oncology Reports · 2026
DOI: 10.3892/or.2026.9052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Chenning Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proto-Oncogene Proteins c-akt, Homeodomain Proteins. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China.
Zitieren
APA
Zhang, C., Jiang, Y., Liu, J., Zhang, W., Qi, J., Wen, Q., & Zhao, H. (2026). HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation. Oncology Reports. https://doi.org/10.3892/or.2026.9052
Vancouver
Zhang C, Jiang Y, Liu J, Zhang W, Qi J, Wen Q, et al. HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation. Oncology Reports. 2026. doi:10.3892/or.2026.9052
BibTeX
@article{Zhang2026,
author = {Zhang, Chenning and Jiang, Yu and Liu, Jiahui and Zhang, Wenyu and Qi, Jie and Wen, Qing and Zhao, Hengli},
title = {HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9052}
}
EUVIMED